PEPTOLITE CHEWABLE TABLETS

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

şimdi satın al

Aktif bileşen:

BISMUTH SUBSALICYLATE

Mevcut itibaren:

PERRIGO ISRAEL AGENCIES LTD, ISRAEL

ATC kodu:

A02BX05

Farmasötik formu:

CHEWABLE TABLETS

Kompozisyon:

BISMUTH SUBSALICYLATE 262 MG

Uygulama yolu:

PER OS

Reçete türü:

Not required

Tarafından üretildi:

PERRIGO COMPANY, USA

Terapötik grubu:

BISMUTH SUBCITRATE

Terapötik alanı:

BISMUTH SUBCITRATE

Terapötik endikasyonlar:

For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

Yetkilendirme tarihi:

2013-07-31

Bilgilendirme broşürü

                                PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is
dispensed without a
doctor’s prescription
PEPTOLITE
CHEWABLE
TABLETS 262 MG
PEPTOLITE
SUSPENSION
262.5 MG/15 ML
Each tablet contains:
Bismuth Subsalicylate 262 mg
Each 15 ml of suspension contains:
Bismuth Subsalicylate 262.5 mg
*Inactive ingredients in the preparation
- see section 6 in the leaflet.
READ THIS PACKAGE INSERT CAREFULLY
IN ITS ENTIRETY BEFORE USING THIS
MEDICINE. This leaflet contains concise
information about the medicine. If you
have further questions refer to your
physician or pharmacist.
The medicine is intended for adults
and children above 12 years of age.
Below the age of 12, you should refer
to your doctor.
The medicine must be used correctly.
Consult the pharmacist if you need
further information. Stop taking the
medicine and contact the physician
if signs of the illness (symptoms)
get worse or do not improve after
two days. Likewise, if the diarrhea
is accompanied by high fever, if you
experience ringing in the ears or loss
of hearing.
1. WHAT IS THE MEDICINE INTENDED
FOR?
The medicine is intended to relieve
cases of diarrhea, nausea, flatulence,
abdominal cramps, upset stomach
and indigestion.
2. BEFORE USING THE MEDICINE:
DO NOT USE THE MEDICINE IF:
• You are sensitive (allergic) to the
active ingredient or to any other
ingredients contained in the
medicine.
• Do not use in children and
adolescents up to 20 years of
age for illnesses accompanied by
fever such as flu and chickenpox
(for fear of Reye’s syndrome).
• The medicine contains salicylate.
Do not use the medicine if you are
allergic to salicylates (including
aspirin) or if you are taking
other preparations that contain
salicylate.
• You have a stomach ulcer,
bleeding, bloody or black stool.
SPECIAL WARNINGS REGARDING USE OF
THE MEDICINE:
• Before starting treatment with
Peptolite tell the doctor if:
you are pregnant or breastfeeding.
you are suffering or have suffered in
the past from impaired function of:

                                
                                Belgenin tamamını okuyun
                                
                            

Diğer dillerdeki belgeler

Bilgilendirme broşürü Bilgilendirme broşürü Arapça 20-08-2017
Bilgilendirme broşürü Bilgilendirme broşürü İbranice 20-08-2017

Belge geçmişini görüntüleyin